Newsletter | May 30, 2023

05.30.23 -- Small Molecule Drug Discovery: Can AI Do It All?
 
Featured Editorial
Small Molecule Drug Discovery: Can AI Do It All?
 
By Anirban Datta, Ph.D., Verseon International Corporation

The hope is that AI can solve the single most challenging problem at the heart of modern drug discovery: the reliable prediction of novel small molecule drugs that potently bind to a disease-causing protein and alter its function. This article discusses the challenges and how we can position ourselves to navigate them.
Industry Insights
Qualified Reference Standards: Setting The Standard For Product Quality
Case Study | By Darryl A. LeBlanc, Ph.D., Cambrex

Qualified reference standards play a critical role in providing validated benchmarks to satisfy regulatory requirements pertaining to purity.
Scale-Up And Site Transfer Of A Semi-Solid Product For Commercial Launch
Case Study | Cambrex

Any changes to the equipment and processes used to produce a semi-solid dosage form may affect the physicochemical characteristics, bioavailability, and qualities of the final product.
A Guide To Finding The Right Cell Culture Media For Your Bioprocesses
e-book | Sartorius

We discuss the challenges and opportunities when developing a media approach and explore the benefits of partnering with a provider with expertise throughout the media pipeline.
Spray Drying For Improved Solubility
Q&A | Lonza

In a recent webinar, experts discussed how to develop a spray-dried powder formulation and scale it from early feasibility studies to commercial manufacturing.
Most Popular News
Life Science Leader Magazine
 

Have you heard of Life Science Leader?
Check it out today for access to candid interviews with top-tier executives on how they do business.